Today, Roche announced they have acquired Bina Technologies. Bina Technologies provides a next- generation genomic analysis platform which provides insight to genomic data. The acquisition demonstrates Roche’s commitment to personalized medicine combining bio-pharma with diagnostics to drive towards personalized medicine therapies. The acquisition demonstrates Life Science companies need to invest in new powerful technologies to support their strategies.
